Organization Profile

You just read:

LIXIANA® (edoxaban) now reimbursed by the Régie de l'assurance maladie du Québec for patients with atrial fibrillation or venous thromboembolism

News provided by

Servier Canada Inc.

Mar 13, 2019, 08:00 ET